Jabbal-Gill I - Search Results

1

Nasal delivery of chitosan-DNA plasmid expressing epitopes of respiratory syncytial virus (RSV) induces protective CTL responses in BALB/c mice.

Iqbal M, Lin W, Jabbal-Gill I, Davis SS, Steward MW, Illum L. Iqbal M, et al. Among authors: jabbal gill i. Vaccine. 2003 Mar 28;21(13-14):1478-85. doi: 10.1016/s0264-410x(02)00662-x. Vaccine. 2003. PMID: 12615444

2

Effective nasal influenza vaccine delivery using chitosan.

Read RC, Naylor SC, Potter CW, Bond J, Jabbal-Gill I, Fisher A, Illum L, Jennings R. Read RC, et al. Among authors: jabbal gill i. Vaccine. 2005 Aug 15;23(35):4367-74. doi: 10.1016/j.vaccine.2005.04.021. Vaccine. 2005. PMID: 15916838

3

Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice.

Jabbal-Gill I, Fisher AN, Rappuoli R, Davis SS, Illum L. Jabbal-Gill I, et al. Vaccine. 1998 Dec;16(20):2039-46. doi: 10.1016/s0264-410x(98)00077-2. Vaccine. 1998. PMID: 9796062

4

A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM(197)) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery.

McNeela EA, O'Connor D, Jabbal-Gill I, Illum L, Davis SS, Pizza M, Peppoloni S, Rappuoli R, Mills KH. McNeela EA, et al. Vaccine. 2000 Dec 8;19(9-10):1188-98. doi: 10.1016/s0264-410x(00)00309-1. Vaccine. 2000. PMID: 11137256

5

Intranasal immunization with genetically detoxified diphtheria toxin induces T cell responses in humans: enhancement of Th2 responses and toxin-neutralizing antibodies by formulation with chitosan.

McNeela EA, Jabbal-Gill I, Illum L, Pizza M, Rappuoli R, Podda A, Lewis DJ, Mills KH. McNeela EA, et al. Among authors: jabbal gill i. Vaccine. 2004 Feb 25;22(8):909-14. doi: 10.1016/j.vaccine.2003.09.012. Vaccine. 2004. PMID: 15161067 Clinical Trial.

6

Potential of polymeric lamellar substrate particles (PLSP) as adjuvants for vaccines.

Jabbal-Gill I, Lin W, Jenkins P, Watts P, Jimenez M, Illum L, Davis SS, Wood JM, Major D, Minor PD, Li X, Lavelle EC, Coombes AG. Jabbal-Gill I, et al. Vaccine. 1999 Sep;18(3-4):238-50. doi: 10.1016/s0264-410x(99)00195-4. Vaccine. 1999. PMID: 10506648

7

Chitosan as a novel nasal delivery system for vaccines.

Illum L, Jabbal-Gill I, Hinchcliffe M, Fisher AN, Davis SS. Illum L, et al. Adv Drug Deliv Rev. 2001 Sep 23;51(1-3):81-96. doi: 10.1016/s0169-409x(01)00171-5. Adv Drug Deliv Rev. 2001. PMID: 11516781 Review.

8

Polymeric lamellar substrate particles for intranasal vaccination.

Jabbal-Gill I, Lin W, Kistner O, Davis SS, Illum L. Jabbal-Gill I, et al. Adv Drug Deliv Rev. 2001 Sep 23;51(1-3):97-111. doi: 10.1016/s0169-409x(01)00173-9. Adv Drug Deliv Rev. 2001. PMID: 11516782 Review.

9

Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigens.

Bacon A, Makin J, Sizer PJ, Jabbal-Gill I, Hinchcliffe M, Illum L, Chatfield S, Roberts M. Bacon A, et al. Infect Immun. 2000 Oct;68(10):5764-70. doi: 10.1128/IAI.68.10.5764-5770.2000. Infect Immun. 2000. PMID: 10992483 Free PMC article.

10

Protective levels of diphtheria-neutralizing antibody induced in healthy volunteers by unilateral priming-boosting intranasal immunization associated with restricted ipsilateral mucosal secretory immunoglobulin a.

Mills KH, Cosgrove C, McNeela EA, Sexton A, Giemza R, Jabbal-Gill I, Church A, Lin W, Illum L, Podda A, Rappuoli R, Pizza M, Griffin GE, Lewis DJ. Mills KH, et al. Among authors: jabbal gill i. Infect Immun. 2003 Feb;71(2):726-32. doi: 10.1128/IAI.71.2.726-732.2003. Infect Immun. 2003. PMID: 12540551 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters